Biotech Mustang Bio Announces Updated Interim Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy June 13, 2022
Biotech Aeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Program June 13, 2022
Biotech aTyr Pharma to Present Findings from its tRNA Synthetase Platform at the International 28th tRNA Conference June 13, 2022
Biotech Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference June 13, 2022
Biotech Akari Therapeutics Announces the Appointment of Accomplished Biotech Executive Melissa Bradford-Klug as Chief Operating Officer to Lead Business Development and Company Growth Strategies June 13, 2022
Biotech Affimed Presents Preclinical Data of Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA) June 10, 2022
Biotech How Much Upside is Left in Anavex Life Sciences (AVXL)? Wall Street Analysts Think 286% June 10, 2022
Biotech AnPac Bio Regains Compliance with Requirements to Remain Listed on Nasdaq Capital Market June 10, 2022
Biotech EyePoint Pharmaceuticals to Present 12-Month Results from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD at the American Society of Retina Specialists 2022 Annual Meeting June 10, 2022